These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation. Melzer AC, Uman J, Au DH. Ann Am Thorac Soc; 2015 Jun; 12(6):831-7. PubMed ID: 25849224 [Abstract] [Full Text] [Related]
23. Impact of Telehealth Interventions on Medication Adherence for Patients With Type 2 Diabetes, Hypertension, and/or Dyslipidemia: A Systematic Review. Bingham JM, Black M, Anderson EJ, Li Y, Toselli N, Fox S, Martin JR, Axon DR, Silva-Almodóvar A. Ann Pharmacother; 2021 May; 55(5):637-649. PubMed ID: 32815400 [Abstract] [Full Text] [Related]
24. Risk factors associated with antihypertensive medication nonadherence in a statewide Medicaid population. Bailey JE, Hajjar M, Shoib B, Tang J, Ray MM, Wan JY. Am J Med Sci; 2014 Nov; 348(5):410-5. PubMed ID: 22885626 [Abstract] [Full Text] [Related]
26. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer. Chopra I, Dwibedi N, Mattes MD, Tan X, Findley P, Sambamoorthi U. J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227 [Abstract] [Full Text] [Related]
29. Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression. Chang CY, Park H, Hincapie-Castillo JM, Heldermon CD, Diaby V, Yang S, Wilson DL, Lo-Ciganic WH. J Manag Care Spec Pharm; 2023 Apr; 29(4):431-445. PubMed ID: 36989452 [Abstract] [Full Text] [Related]
35. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia. Chopra I, Kamal KM. Hosp Pract (1995); 2014 Apr 20; 42(2):77-88. PubMed ID: 24769787 [Abstract] [Full Text] [Related]
36. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Calip GS, Boudreau DM, Loggers ET. Breast Cancer Res Treat; 2013 Feb 20; 138(1):225-33. PubMed ID: 23358904 [Abstract] [Full Text] [Related]
37. Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population-Based Cohort Study in Japan. Matsumoto M, Harada S, Ikuta H, Iida M, Kato S, Sata M, Shibuki T, Ishibashi Y, Miyagawa N, Hisamatsu M, Hirata A, Kuwabara K, Takeuchi A, Sugiyama D, Suzuki S, Nakamura T, Okamura T, Takebayashi T. Pharmacoepidemiol Drug Saf; 2024 Aug 20; 33(8):e5855. PubMed ID: 39145400 [Abstract] [Full Text] [Related]
39. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010. Tuppin P, Ricci-Renaud P, de Peretti C, Fagot-Campagna A, Gastaldi-Menager C, Danchin N, Alla F, Allemand H. Arch Cardiovasc Dis; 2013 May 20; 106(5):274-86. PubMed ID: 23769402 [Abstract] [Full Text] [Related]
40. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Diabetes Care; 2004 Dec 20; 27(12):2800-5. PubMed ID: 15562188 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]